An investigational three-dose Lyme vaccine (VLA15) against Borrelia outer surface protein A (OspA)-specific serotypes generated immunogenicity and appeared safe, according to results of two linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results